Palmoplantar keratoderma-deafness syndrome is a rare genetic condition that affects the skin of the hands and feet and hearing. People with palmoplantar keratoderma-deafness syndrome often have thick, tough skin on the palms and soles that can crack and feel painful. Hearing loss is usually present from childhood or the teen years and is commonly sensorineural. The condition is lifelong, but treatment can improve comfort and communication. Care includes moisturizers, keratolytic creams, careful foot and hand care, and hearing aids or cochlear implants, and not everyone will have the same experience.
Overview
Palmoplantar keratoderma-deafness syndromeSymptoms
Early signs of Palmoplantar keratoderma‑deafness syndrome include thick, hard skin on the palms and soles, sometimes with painful cracks or blisters. Many also have early hearing loss. Walking, sports, or gripping objects can become uncomfortable; nails may change.
Outlook and prognosis
Most people with Palmoplantar keratoderma-deafness syndrome lead full lives, though the thickened skin on the palms and soles and varying degrees of hearing loss often need ongoing care. Early treatment—protective skincare and hearing support—helps daily function and independence. Severity can vary within families, so tailored follow-up is important.
Causes and risk factors
Most cases result from mutations in the GJB2 gene affecting connexin 26, usually inherited in an autosomal‑dominant pattern; some arise de novo. Family history is the main risk. Friction, heat, and moisture can worsen palmoplantar thickening but don’t cause it.
Genetic influences
Genetics play a central role in Palmoplantar keratoderma-deafness syndrome. Most cases result from inherited variants affecting skin and inner-ear function, often in a single gene. Knowing the exact variant guides prognosis, family planning, and options like genetic counseling and testing.
Diagnosis
Doctors suspect Palmoplantar keratoderma-deafness syndrome when thickened skin on the palms and soles occurs with early hearing loss. Diagnosis is clinical, supported by hearing tests. Genetic tests can confirm the genetic diagnosis of Palmoplantar keratoderma-deafness syndrome.
Treatment and drugs
Treatment for palmoplantar keratoderma–deafness syndrome focuses on skin care and hearing support. Dermatologists often use urea or salicylic acid creams, keratolytics, and careful debridement to soften thickened skin, plus treat cracks to prevent infection. Audiologists fit hearing aids or consider cochlear implants, alongside communication supports.
Symptoms
Palmoplantar keratoderma-deafness syndrome affects the skin of the hands and feet and a person’s hearing. Early features of Palmoplantar keratoderma-deafness syndrome often include thick, tough skin on the palms and soles and hearing loss present at birth or in early childhood. Features vary from person to person and can change over time. These traits can make daily tasks like walking longer distances, gripping tools, or following speech in noisy rooms more challenging.
In medical terms, this is keratoderma; in everyday life, it shows up as thick, tough skin on the palms and soles. For many people with palmoplantar keratoderma-deafness syndrome, the skin can feel tight or tender and may form callus-like areas that snag or split.
Hearing loss is often present at birth or starts in early childhood and is sensorineural (inner ear). People with palmoplantar keratoderma-deafness syndrome commonly have this type of hearing loss. It can make it harder to follow speech, especially with background noise, and may affect speech development without early support.
The thick skin can split, causing painful cracks that may bleed. These spots can be sore with pressure and can sometimes become infected.
Thickened skin on the soles can make standing, long walks, or running painful. Many find hard floors tougher to tolerate and may need more breaks when on their feet.
How people usually first notice Palmoplantar keratoderma-deafness syndrome?
Many families first notice palmoplantar keratoderma–deafness syndrome when a baby or young child seems slow to respond to soft sounds or voices, leading to evaluation and a diagnosis of sensorineural hearing loss. Around the same time or a bit later, thickened, rough skin develops on the palms and soles (palmoplantar keratoderma), which can look yellowish, feel hard, and sometimes crack or become sore, making walking or using the hands uncomfortable. These first signs of palmoplantar keratoderma–deafness syndrome are often recognized in early childhood, though newborn hearing screening or a family history may prompt earlier testing.
Types of Palmoplantar keratoderma-deafness syndrome
Palmoplantar keratoderma–deafness syndrome is a rare, inherited condition with more than one recognized clinical variant. Most are linked to changes in connexin genes that help neighboring cells “talk,” which can alter skin thickness on the palms/soles and hearing in different ways. People may notice different sets of symptoms depending on their situation. When reading about types of Palmoplantar keratoderma–deafness syndrome, you’ll see differences in when hearing loss begins, how fast it progresses, and the pattern or severity of skin thickening.
GJB2 (connexin 26)
This variant often causes childhood-onset sensorineural hearing loss that tends to be bilateral and progressive. The palm and sole skin may show diffuse thickening early in life with painful fissures during activity.
GJB6 (connexin 30)
Hearing loss can begin in childhood or adolescence and may progress more slowly than in some other variants. Palmoplantar keratoderma can be patchy or focal, sometimes worsening with friction or heat.
GJB3 (connexin 31)
Some with this variant have milder or later-onset hearing loss compared with other types of Palmoplantar keratoderma–deafness syndrome. Skin changes may be less uniform, with areas of thickening that flare under mechanical stress.
GJB1 (connexin 32)
Hearing changes may range from mild to moderate and can vary by family. Palm and sole thickening may be moderate, with occasional fissuring and increased tenderness after prolonged standing or walking.
Clinical spectrum notes
Not everyone will experience every type. The balance of symptoms can shift over time.
What genetics can tell you about symptoms
Certain mutations in the GJB2 gene, which makes a protein that connects neighboring cells, can thicken skin on the palms and soles while also disrupting inner-ear signaling. People with these variants often develop early-onset palm and sole callusing plus sensorineural hearing loss.
Causes and risk factors
Palmoplantar keratoderma-deafness syndrome is most often caused by a change in the GJB2 gene, also called connexin 26. It is usually inherited from one parent, but it can also arise as a new change. Genes set the stage, but environment and lifestyle often decide how the story unfolds. Loud noise can speed hearing decline, and repeated friction, pressure, or very dry air can make the palm and sole thickening worse. Family history or early symptoms of Palmoplantar keratoderma-deafness syndrome in relatives can signal higher inherited risk.
Environmental and biological risk factors
Palmoplantar keratoderma-deafness syndrome usually starts early in life, but what raises the chance of it occurring begins even earlier, around conception. While early symptoms of Palmoplantar keratoderma-deafness syndrome often draw attention first, the points below focus on biological and environmental factors that may influence risk. Some risks are carried inside the body, others come from the world around us. These influences do not guarantee the condition; they only shift the odds slightly.
Older paternal age is linked to more new changes in sperm. This can slightly raise the chance of a rare condition like Palmoplantar keratoderma-deafness syndrome starting for the first time in a family. The effect tends to increase gradually with each decade.
Older maternal age is mainly tied to chromosome conditions, not this specific syndrome. Even so, age-related changes in eggs may modestly raise the chance of new changes at conception. Overall risk remains low for any one rare condition.
High-dose radiation to the ovaries or testes before conception can damage reproductive cells. This may increase the chance of new changes that could, rarely, lead to a condition present from birth. Modern care uses shielding to keep exposure as low as possible.
Some chemotherapy medicines and pelvic radiation can harm egg or sperm. If exposure happens before conception, there may be a small increased chance of rare conditions in children, including, very rarely, conditions such as Palmoplantar keratoderma-deafness syndrome. Doctors can advise on timing of pregnancy and protection to reduce risk.
Genetic risk factors
Palmoplantar keratoderma-deafness syndrome often runs in families because of changes in a skin and hearing gene called GJB2. These changes affect tiny channels between cells, which can lead to thickened palms and soles and hearing loss, sometimes starting in childhood. Carrying a genetic change doesn’t guarantee the condition will appear, but knowing the genes involved can help families recognize early symptoms of Palmoplantar keratoderma-deafness syndrome.
GJB2 variants: Changes in the GJB2 gene (connexin 26) are the main genetic cause. They alter how neighboring cells share signals in the inner ear and skin. This drives the combination of palm-sole thickening and sensorineural hearing loss.
Connexin channel changes: Connexin proteins form tiny channels that move ions and small molecules between cells. When these channels do not work properly, inner ear signaling and skin renewal are disrupted. This biological pathway explains both features of Palmoplantar keratoderma-deafness syndrome.
Autosomal dominant inheritance: A parent with a causative GJB2 change has a 50% chance to pass it to each child. Both sexes are equally likely to inherit it. Severity can differ between relatives.
Family history: Having a close relative with confirmed GJB2-related PPK-deafness raises personal risk. In some families, skin signs appear first, while hearing changes emerge later. Knowing this pattern can guide earlier checks.
De novo variants: Sometimes the genetic change arises for the first time in a child, so there is no prior family history. In these situations, the chance that siblings are affected is usually low. Testing parents can clarify the recurrence risk.
Variable expressivity: The same genetic change can lead to different mixes of skin and hearing findings, even within one family. Some people have mild calluses, while others have thicker plaques and earlier hearing loss. This variability can affect when a diagnosis is recognized.
Rare parental mosaicism: Very rarely, a parent carries the change in a portion of their egg or sperm cells but has minimal or no features. This mosaicism can slightly increase the chance of another affected child even if parental blood testing is negative. A genetics team can discuss this uncommon scenario.
Variant-specific effects: Some GJB2 changes are tied more strongly to the combined skin-hearing pattern than others that cause hearing loss alone. The exact variant can influence age at onset and severity. Genetic results help tailor counseling for a given family.
Lifestyle risk factors
Palmoplantar keratoderma-deafness syndrome is a genetic condition; lifestyle habits do not cause it, but they can shape symptom severity, complications, and day-to-day function. Practical choices can reduce skin thickening, fissures, pain, infection risk, and protect hearing. Below are examples of how lifestyle affects Palmoplantar keratoderma-deafness syndrome.
Repetitive rubbing and pressure thicken callused skin and trigger painful fissures. Using gloves, cushioned grips, and rest breaks lowers trauma and infection risk.
Tight or non-breathable shoes increase sweat, shear, and cracking. Cushioned, wide, and breathable footwear with moisture-wicking socks reduces fissures and pain.
Excess sweating macerates skin and deepens splits, while too-dry skin cracks easily. Scheduled soaks, keratolytics, and emollients keep skin flexible and less likely to fissure.
Strong soaps, solvents, and frequent hot-water washing strip the barrier and worsen hyperkeratosis. Gentle cleansers and immediate moisturization reduce inflammation and tenderness.
Risk prevention
Palmoplantar keratoderma-deafness syndrome is inherited, so the condition itself can’t be fully prevented. Prevention is about lowering risk, not eliminating it completely. You can reduce painful skin thickening, cracks, and infections, and protect hearing over time. Early care and regular check-ins help spot changes before they cause bigger problems.
Soak hands and feet in lukewarm (not hot) water, then apply a rich moisturizer to lock moisture in. Avoid harsh scrubbing, which can tear skin and lead to cracks.
Use thick creams or ointments with urea or lactic acid to soften thickened skin on the palms and soles. Apply after bathing and before bed to reduce splitting and soreness.
Choose cushioned, well-fitting shoes and soft socks to limit rubbing on the soles. For tasks with repeated hand friction, wear well-padded gloves to protect the skin.
At the first sign of fissures, seal with thick ointment and a simple bandage to help them close. Deep or painful cracks should be checked and trimmed safely by a clinician to avoid infection.
Transmission
Palmoplantar keratoderma-deafness syndrome does not spread between people by touch, droplets, or blood; it isn’t contagious. The genetic transmission of Palmoplantar keratoderma-deafness syndrome is usually autosomal dominant—if a parent has the condition, each child has a 50% (1 in 2) chance of inheriting it. In some families, it happens because of a new change in a gene (a de novo mutation), so parents may be unaffected. Rarely, it follows an autosomal recessive pattern, where both parents silently carry one altered gene and there’s a 25% (1 in 4) chance a child will be affected with each pregnancy. Genetic counseling can help clarify how Palmoplantar keratoderma-deafness syndrome is inherited in your family.
When to test your genes
Genetic testing is reasonable if you or close relatives have both early-onset thickened skin on the palms/soles and sensorineural hearing loss, or if a clinician suspects a keratin gene cause. Testing can confirm the diagnosis, guide hearing support and skin care, and inform family planning. Discuss results with a genetic counselor.
Diagnosis
For many, the first step comes when everyday activities start feeling harder—hands that crack with routine tasks or early hearing challenges in school or work. Doctors look for the recognizable pairing of thickened skin on the palms and soles along with sensorineural hearing loss, then confirm with targeted tests. Family history is often a key part of the diagnostic conversation. The diagnosis of Palmoplantar keratoderma-deafness syndrome is usually made by combining clinical findings with genetic testing.
A dermatologist looks for thickened, sometimes fissured skin on the palms and soles and notes distribution and severity. These clinical features help point toward Palmoplantar keratoderma-deafness syndrome and guide next tests.
An audiologist checks inner-ear (sensorineural) hearing using age-appropriate exams like audiometry or otoacoustic emissions. The pattern and degree of loss can support the suspected diagnosis and help plan hearing support.
A blood or saliva test analyzes genes linked to palmoplantar keratoderma and hearing loss, such as GJB2 and related genes. A confirmed variant provides genetic diagnosis of Palmoplantar keratoderma-deafness syndrome and can inform family counseling.
Clinicians map who else in the family has thickened palms/soles or hearing differences and the age they began. This helps identify inheritance patterns and who else might benefit from testing.
Stages of Palmoplantar keratoderma-deafness syndrome
Palmoplantar keratoderma-deafness syndrome does not have defined progression stages. Early symptoms of palmoplantar keratoderma-deafness syndrome often include thickened skin on the palms and soles and reduced hearing from early life, but these features vary between people and do not follow a standard, step-by-step pattern. Different tests may be suggested to help confirm the diagnosis, such as a skin exam, hearing tests (audiogram), and genetic testing for connexin-related genes. Follow-up typically includes regular hearing assessments and skin evaluations with dermatology and audiology, and genetic counseling may be offered for you and family members.
Outlook and prognosis
Looking ahead can feel daunting, but most people with Palmoplantar keratoderma-deafness syndrome can lead long, full lives with the right care. The condition usually involves thickened skin on the palms and soles plus sensorineural hearing loss that starts in childhood or teen years. Many people ask, “What does this mean for my future?”, and the honest answer is that the skin and hearing changes tend to be lifelong, but they can often be managed so daily routines—work, school, exercise—remain possible with adaptations.
Prognosis refers to how a condition tends to change or stabilize over time. For Palmoplantar keratoderma-deafness syndrome, the thickened skin often persists and may slowly progress, with periods when calluses crack or get sore, especially with friction or standing. Early symptoms of Palmoplantar keratoderma-deafness syndrome, such as painful fissures or difficulty hearing in noisy rooms, can be eased with regular skin care, protective footwear, and timely hearing support. Hearing loss may gradually worsen, but many maintain good communication using hearing aids, assistive listening devices, or—when needed—cochlear implants. Severe complications are uncommon; life expectancy is generally normal, and mortality is not increased by the syndrome itself.
Everyone’s journey looks a little different. Some people have mild skin issues and moderate hearing loss, while others need ongoing podiatry care and advanced hearing technology to stay comfortable and connected. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, so avoiding skin friction, treating small cracks early to prevent infection, and protecting hearing from loud noise can all help. Talk with your doctor about what your personal outlook might look like, including how often to monitor hearing and what to do if skin pain, infections, or sudden changes appear.
Long-term effects
Palmoplantar keratoderma-deafness syndrome can have lifelong effects on skin and hearing that shape daily routines at home, school, and work. Long-term effects vary widely, and they can change over time from childhood into adulthood. People sometimes recall the early symptoms of Palmoplantar keratoderma-deafness syndrome as thickened skin on the palms and soles alongside childhood-onset hearing changes. For most, overall life expectancy is typical, though the condition’s features may remain throughout life.
Thickened skin on the palms and soles typically continues across the lifespan. The degree of thickening can rise and fall over time.
Cracks in thickened skin can be painful and may bleed. This can make standing, walking long distances, or gripping objects harder on some days.
Walking or running on firm surfaces can feel uncomfortable when skin is very thick or cracked. Fine motor tasks or manual work may take more effort.
Areas of thick or split skin have a higher risk of bacterial or fungal infections. Episodes can recur over the years, especially on weight-bearing areas.
How is it to live with Palmoplantar keratoderma-deafness syndrome?
Living with Palmoplantar keratoderma–deafness syndrome often means planning around your skin and hearing every single day—managing thickened, sometimes painful skin on the palms and soles to stay active at work or school, and using hearing aids or other supports to follow conversations without strain. Many find that regular skin care, well-fitted footwear, and scheduled hearing checks reduce setbacks, while clear communication strategies—like face-to-face speaking and quiet settings—make social time less tiring. Family, friends, and coworkers may need to adjust expectations a bit—allowing extra time for walking on sore days, using captions or written notes, and keeping noise down—but these small shifts can make participation feel easier and more equal. With a consistent routine and supportive people around you, most day-to-day goals remain reachable, just approached with a bit more planning and teamwork.
Treatment and drugs
Palmoplantar keratoderma-deafness syndrome is managed by treating the skin changes on the palms and soles and supporting hearing, since there’s no single cure for the underlying condition. For the skin, dermatologists often use thick moisturizers, urea or salicylic acid creams to soften hard skin, and carefully timed removal of thickened areas; in tougher cases, oral retinoids may be considered with regular monitoring. For hearing loss, early fitting of hearing aids, assistive listening devices, and hearing therapy can improve communication; some people may be candidates for cochlear implants if hearing aids aren’t enough. Alongside medical treatment, lifestyle choices play a role, including protective footwear, reducing friction and pressure on the feet and hands, and prompt care for cracks to prevent infection. Not every treatment works the same way for every person, so regular follow-up with dermatology and audiology helps adjust the plan over time.
Non-drug treatment
Palmoplantar keratoderma-deafness syndrome affects both the skin of the hands and feet and hearing, so care often blends skincare, foot support, and communication help. Non-drug treatments often lay the foundation for comfort, mobility, and connection in daily life. Many people do best with a team approach that may include dermatology, podiatry, audiology, and rehabilitation. Plans are tailored to age, lifestyle, and how severe the skin thickening or hearing changes are.
Soak hands and feet in lukewarm water, then seal in moisture with a thick, fragrance-free cream or ointment. Gentle exfoliation with a soft file or pumice can smooth rough areas, but avoid aggressive scrubbing that can cause cracks.
Regular visits to a podiatrist for careful trimming and thinning of thick skin can reduce pain and pressure. This can also lower the chance of splits and infections.
Supportive, roomy shoes with cushioned insoles and moisture-wicking socks reduce friction and pressure points. Gel pads or custom orthotics can redistribute weight to make walking more comfortable.
Soft cotton or silicone-lined gloves during tasks that cause friction can protect the skin. For some, wearing cotton liners under work gloves helps reduce sweat and irritation.
Your genes may have an impact on how drugs work for you
Medicines for palmoplantar keratoderma–deafness syndrome can work differently based on genes that affect skin cell turnover, inflammation pathways, and how the body processes drugs. Genetic differences may change effectiveness or side‑effect risk, so personalized dosing and choices can help.
Pharmacological treatments
Medications for palmoplantar keratoderma-deafness syndrome focus on easing thick, painful skin and treating problems that flare because of it, like fissures, infections, or sweating-related irritation. There isn’t a cure yet, but several drug options can soften skin, reduce pain, and lower the risk of splits and infection. Hearing loss in this condition is usually managed with devices rather than medicine. Drugs that target symptoms directly are called symptomatic treatments.
Urea 20–40% and salicylic acid 3–6% creams help thin thickened skin and ease scaling. They can make cracks less likely by keeping the skin more flexible. When early symptoms of palmoplantar keratoderma-deafness syndrome include painful splits, these agents can reduce soreness.
Lactic acid 10–12% lotions gently dissolve built-up skin and improve moisture. Regular use can soften callus-like areas on palms and soles. Some may notice mild stinging at first that often settles.
Tazarotene 0.05–0.1% can slow overgrowth of skin and smooth rough patches. It may be used on thickest spots a few nights per week, then adjusted as tolerated. Redness or irritation can occur, so start slowly.
Acitretin is the most used oral option to reduce severe thickening; isotretinoin or alitretinoin may be considered off-label. Regular blood tests and pregnancy precautions are essential due to potential side effects. Dosing may be increased or lowered gradually to balance results with tolerability.
Genetic influences
Most cases are caused by a single gene change that disrupts how skin and inner‑ear cells communicate, most often in the GJB2 gene (which makes the connexin 26 protein). Palmoplantar keratoderma-deafness syndrome usually follows an autosomal dominant pattern, meaning one altered copy can cause the condition and each child of an affected parent has a 1‑in‑2 (50%) chance of inheriting it. Sometimes the change happens for the first time in a child, so there may be no prior family history, and severity can vary widely even among relatives who share the same change. Early symptoms of Palmoplantar keratoderma-deafness syndrome may include thickened skin on the palms and soles in childhood and hearing changes present at birth or appearing early on. DNA testing can sometimes identify these changes. If a change is found, your care team can explain what it means for you and your family and discuss options for hearing support and skin care.
Is Palmoplantar keratoderma-deafness syndrome genetic?
Genetics play a central role in Palmoplantar keratoderma-deafness syndrome. Most cases result from inherited variants affecting skin and inner-ear function, often in a single gene. Knowing the exact variant guides prognosis, family planning, and options like genetic counseling and testing.
Pharmacogenetics—how genetics influence drug effects
Care for this condition often combines skin treatments with hearing support, and genetics can shape parts of that plan. The gene change behind palmoplantar keratoderma-deafness syndrome usually doesn’t dictate which moisturizers, keratolytics, or retinoids are used, but it may help set expectations for hearing-aid or cochlear implant results. One clear drug–gene issue is a group of antibiotics called aminoglycosides (for example, gentamicin): a specific mitochondrial gene variant can trigger sudden, permanent hearing loss after even small exposures. Alongside medical history and other factors, genetic testing can help doctors spot this risk and choose different antibiotics when possible. If pain relief is needed for deep, painful cracks, general pharmacogenetic guidance that applies to anyone may be relevant too, such as differences in genes that change how codeine is activated in the body. At this time, pharmacogenetics does not routinely guide day-to-day dosing of most medications for palmoplantar keratoderma-deafness syndrome, so regular follow-up and careful monitoring remain important.
Interactions with other conditions
Day-to-day, infections and other health issues can make the skin and hearing features feel more intense. Cracked, thick skin on the hands and feet is slower to heal and more prone to bacterial or fungal infections; if someone also lives with diabetes or poor circulation, those infections may be more frequent and harder to clear. A condition may “exacerbate” (make worse) symptoms of another, so athlete’s foot or eczema can deepen fissures in palmoplantar keratoderma-deafness syndrome and add pain with walking or using the hands. On the hearing side, recurrent ear infections, loud noise exposure, and certain medicines that affect the inner ear (such as some chemotherapy drugs, specific antibiotics, or high-dose “water pills”) can further reduce hearing in people with Palmoplantar keratoderma-deafness syndrome. Families may also notice that relatives without the skin changes can have isolated hearing loss, reflecting shared inherited factors rather than a separate disease. It’s worth reviewing your full medication list and any chronic conditions with your care team so treatments are coordinated and skin and hearing are protected.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described families where several relatives had very thick skin on the palms and soles along with trouble hearing conversations, even as children. A grandparent might have worn sturdy gloves to work because their hands cracked easily, while a grandchild needed to sit near the front of the classroom to catch the teacher’s words. These everyday stories prompted doctors to look for a link between skin changes on the hands and feet and gradual hearing loss.
First described in the medical literature as a clustering of hard, callus-like skin on the palms and soles with sensorineural hearing loss, early reports focused on what could be seen and heard in the clinic. Over time, descriptions became clearer: the skin thickening tended to appear in early childhood, while the hearing changes often emerged later in childhood or the teen years. Some families showed the pattern in every generation, which led clinicians to suspect a dominantly inherited condition long before the underlying cause was known.
From early theories to modern research, the story of Palmoplantar keratoderma-deafness syndrome traces how careful observation led to genetic answers. In the late 20th century and early 2000s, advances in genetics confirmed that changes in a skin–ear connection protein called a connexin can disrupt cell-to-cell signaling, explaining why both the palm–sole skin and the inner ear are affected. This helped unify earlier case reports that had used different names and criteria, and it clarified why the condition can vary from one family to another.
Once considered rare, now recognized as a distinct inherited syndrome, it has been refined by reports from many countries and backgrounds. Some historical papers emphasized painful fissures and infections of the feet; others highlighted progressive hearing loss as the main challenge. Not every early description was complete, yet together they built the foundation of today’s knowledge. Researchers also learned that age of onset and severity can differ within the same family, which explains why some relatives remembered only “tough feet,” while others needed hearing aids in school.
With each decade, improvements in hearing tests, skin imaging, and genetic testing have shifted care from labeling to practical support. Knowing the condition’s history shows why early symptoms of Palmoplantar keratoderma-deafness syndrome might be missed or misattributed to “stubborn calluses” or “childhood ear issues.” Today, recognizing the combined pattern guides timely hearing support, tailored skin care, and family counseling, while ongoing research continues to refine the picture first sketched by families’ lived experiences.